Purchase Order 75N92019P00047
Award Date 1/13/19
Potential Completion Date 1/12/20
Potential Value $37K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for an LSRFortessa multi-year maintenance agreement with a ceiling value of $283,987.80, awarded November 17, 2014, with ultimate completion November 20, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. This is a maintenance agreement supporting flow cytometry instrumentation at a federal research facility, typical of BD...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Becton, Dickinson And Company (BD) on January 10, 2020 for the maintenance of a BD Fortessa flow cytometer analyzer. The contract has a potential value of $223,064.40 and a completion date of January 12, 2025. The place of performance is Bethesda, Maryland. BD is a global medical technology company that provides a...
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company, Infectious Disease Systems division, on August 9, 2017, with a ceiling value of $680,675.70 for maintenance of BD LSR Fortessa SORP flow cytometry analyzer with high throughput sampler and BD Influx cell sorter equipment. The order carries no set-aside designation and is priced on a firm fixed-price basis. Work is performed in Bethesda, Maryland. Ultimate completion is scheduled for August...
- Becton, Dickinson and Company (BD) was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute to provide maintenance services for a BD Biosciences Fortessa flow cytometer. The potential value of this contract is $147,863.40. No set-aside designation was used for this award. Performance will occur in Bethesda, Maryland and continue through January 31, 2025. This award is associated with the...
- The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson and Company on October 18, 2018, with a ceiling value of $24,047.48 for maintenance service on a FACS Fortessa X-20 flow cytometer system. The order covers the period from October 18, 2018, through October 17, 2019. Work is performed at the Laboratory of Molecular Immunology in Bethesda, MD. The order is priced firm fixed price with quarterly arrears billing. This delivery order is issued under the GSA...
- On January 13, 2025, the National Heart Lung and Blood Institute (NHLBI) awarded a firm fixed-price purchase order valued at $51,828.84 to Becton, Dickinson and Company's BD Biosciences division for maintenance services on a Fortessa flow cytometer analyzer. The contract, designated as part of the FY26 UDO Initiative, has an ultimate completion date of January 12, 2026, and will be performed in San Jose, California. This award requires no small business set-aside and represents a child...
- The National Heart Lung and Blood Institute (NHLBI) awarded a maintenance contract to Becton, Dickinson and Company's BD Biosciences division for the BD Fortessa Flow Cytometer Analyzer on February 1, 2026. This firm fixed-price purchase order, valued at $42,476.04 with completion scheduled for January 31, 2027, supports the NHLBI's biomedical research infrastructure. The contract covers maintenance services for the BD Fortessa, a sophisticated flow cytometry instrument used in cellular and...
- This is a firm fixed-price service contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the maintenance of a Fortessa X-20 flow cytometry instrument. The contract period is from August 18, 2017, to August 17, 2018, with a ceiling value of $24,047.88. BD, a global medical technology company, is the prime contractor for this contract, which does not have a small business...
- This firm fixed price purchase order was awarded by the National Heart Lung and Blood Institute, a civilian agency of the U.S. government, to Becton, Dickinson and Company (BD) for LSRFortessa maintenance services. The $219,675 contract has a ceiling value and a performance period ending on September 30, 2025. The award does not utilize a set-aside designation. BD, a global medical technology company, will provide maintenance services for the agency's LSRFortessa instruments, which are...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $64,908 firm fixed price purchase order to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for maintenance services for the CantoiI flow cytometer analyzer. The prime contractor, Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division, will provide maintenance services for the flow cytometer located in Bethesda, Maryland...